A trial published in the New England Journal of Medicine found that participants using tirzepatide lost up to 20.9% of their body weight over 72 weeks, with results improving progressively at higher doses across all treatment groups (Jastreboff et al., NEJM, 2022, Michigan residents across the state, from Detroit to the Upper Peninsula, have real and practical access to tirzepatide today
Carnitine Comprehensive information on carnitine for treating alcohol-related liver disease, chronic fatigue syndrome, Peyronie's Disease and hyperthyroidism
It shouldn't replace other healthy habits but rather complement them as part of a holistic approach to aging gracefully
In the db/db mouse model of type 2 diabetes, chronic treatment with liraglutide markedly reduced AF susceptibility, an effect that was attributed to improvements in atrial conduction and electrical remodelling and a notable decrease in atrial fibrosis 243
Willows message has been clear from the get-go: you dont need to be overweight or obese to benefit from GLP-1 medications
The key principle is that protein intake should be the last thing you compromise when appetite drops
